TY - JOUR
T1 - Neonatal intracranial hemorrhage
T2 - II. Risk factor analysis in an inborn population
AU - Wallin, Lawrence A.
AU - Rosenfeld, Charles R.
AU - Laptook, Abbot R.
AU - Maravilla, Ann M.
AU - Strand, Cynthia
AU - Campbell, Nancy
AU - Dowling, Sharon
AU - Lasky, Robert E.
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1990/8
Y1 - 1990/8
N2 - The ability to predict the occurrence of neonatal periventricular-intraventricular hemorrhage (PVH-IVH) would be useful in the design of clinical trials to prevent its occurrence. Therefore, data were collected from 463 consecutive infants ≤1500 g birth weight delivered between March 1, 1982 and February 28, 1985. This large population made it feasible to divide the infants into two groups, using one group to develop a model predictive of ICH and the second group to test the validity of the model. Infants were randomly grouped by sex, race, gestational age, birth weight, month of birth, mortality, and incidence and grade of worst PVH-IVH. In Group A (n = 232), respiratory distress syndrome, ventilator therapy, PaCO2 ≥ 60 mmHg, Po2 ≤ 40 mmHg ≥ 2 h, lower 1- and 5-min Apgar scores, lower pediatric estimation of gestational age, and pneumothorax were significantly associated with PVH-IVH by univariant analyses (χ2, P < 0.03). Multivariant discriminant analysis performed on Group A revealed that pneumothorax, cesarean section, PaCO2, and ventilator therapy were most predictive of PVH-IVH, but sensitivity was 55% and specificity 78%. Applying the model to Group B, sensitivity decreased to 21% while specificity rose to 93%. Logistic regression, which takes into account non-normally distributed variables, did not improve predictability. Although the clinical factors associated with the occurrence of PVH-IVH in our large inborn population of low-birth-weight infants do not differ from earlier reports, we were unable to develop an adequate model predictive for PVH-IVH. Thus, many of these factors may be associations rather than causative.
AB - The ability to predict the occurrence of neonatal periventricular-intraventricular hemorrhage (PVH-IVH) would be useful in the design of clinical trials to prevent its occurrence. Therefore, data were collected from 463 consecutive infants ≤1500 g birth weight delivered between March 1, 1982 and February 28, 1985. This large population made it feasible to divide the infants into two groups, using one group to develop a model predictive of ICH and the second group to test the validity of the model. Infants were randomly grouped by sex, race, gestational age, birth weight, month of birth, mortality, and incidence and grade of worst PVH-IVH. In Group A (n = 232), respiratory distress syndrome, ventilator therapy, PaCO2 ≥ 60 mmHg, Po2 ≤ 40 mmHg ≥ 2 h, lower 1- and 5-min Apgar scores, lower pediatric estimation of gestational age, and pneumothorax were significantly associated with PVH-IVH by univariant analyses (χ2, P < 0.03). Multivariant discriminant analysis performed on Group A revealed that pneumothorax, cesarean section, PaCO2, and ventilator therapy were most predictive of PVH-IVH, but sensitivity was 55% and specificity 78%. Applying the model to Group B, sensitivity decreased to 21% while specificity rose to 93%. Logistic regression, which takes into account non-normally distributed variables, did not improve predictability. Although the clinical factors associated with the occurrence of PVH-IVH in our large inborn population of low-birth-weight infants do not differ from earlier reports, we were unable to develop an adequate model predictive for PVH-IVH. Thus, many of these factors may be associations rather than causative.
KW - low-birth-weight
KW - periventricular-intraventricular hemorrhage
KW - risk factors
KW - sonography
UR - http://www.scopus.com/inward/record.url?scp=0025144354&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025144354&partnerID=8YFLogxK
U2 - 10.1016/0378-3782(90)90136-7
DO - 10.1016/0378-3782(90)90136-7
M3 - Article
C2 - 2124183
AN - SCOPUS:0025144354
SN - 0378-3782
VL - 23
SP - 129
EP - 137
JO - Screening
JF - Screening
IS - 2
ER -